| Literature DB >> 27027805 |
Valentina Di Foggia1, Priyanka Makwana1, Robin R Ali2, Jane C Sowden1.
Abstract
Stem cell therapies are being explored as potential treatments for retinal disease. How to replace neurons in a degenerated retina presents a continued challenge for the regenerative medicine field that, if achieved, could restore sight. The major issues are: (i) the source and availability of donor cells for transplantation; (ii) the differentiation of stem cells into the required retinal cells; and (iii) the delivery, integration, functionality, and survival of new cells in the host neural network. This review considers the use of induced pluripotent stem cells (iPSC), currently under intense investigation, as a platform for cell transplantation therapy. Moreover, patient-specific iPSC are being developed for autologous cell transplantation and as a tool for modeling specific retinal diseases, testing gene therapies, and drug screening.Entities:
Mesh:
Year: 2016 PMID: 27027805 PMCID: PMC4904163 DOI: 10.1089/jop.2015.0143
Source DB: PubMed Journal: J Ocul Pharmacol Ther ISSN: 1080-7683 Impact factor: 2.671